Travere Therapeutics Inc’s recent filing unveils that its CHIEF FINANCIAL OFFICER Cline Christopher R. unloaded Company’s shares for reported $37553.0 on May 05 ’25. In the deal valued at $21.05 per share,1,784 shares were sold. As a result of this transaction, Cline Christopher R. now holds 93,126 shares worth roughly $1.43 million.
Then, Dube Eric M sold 18,924 shares, generating $398,350 in total proceeds. Upon selling the shares at $21.05, the CHIEF EXECUTIVE OFFICER now owns 419,173 shares.
Before that, Heerma Peter sold 1,771 shares. Travere Therapeutics Inc shares valued at $37,280 were divested by the CHIEF COMMERCIAL OFFICER at a price of $21.05 per share. As a result of the transaction, Heerma Peter now holds 128,215 shares, worth roughly $1.96 million.
Cantor Fitzgerald initiated its Travere Therapeutics Inc [TVTX] rating to an Overweight in a research note published recently. A number of analysts have revised their coverage, including Wells Fargo’s analysts, who increased its forecast for the stock in late October from “an Equal weight” to “an Overweight”. Scotiabank began covering TVTX with “Sector outperform” recommendation on October 16, 2024. Guggenheim revised its rating on September 09, 2024. It rated TVTX as “a Buy” which previously was an “a Neutral”.
Price Performance Review of TVTX
On Friday, Travere Therapeutics Inc [NASDAQ:TVTX] saw its stock jump 4.08% to $15.32. Over the last five days, the stock has gained 2.00%. Travere Therapeutics Inc shares have fallen nearly -12.06% since the year began. Nevertheless, the stocks have risen 99.74% over the past one year. While a 52-week high of $25.29 was reached on 02/11/25, a 52-week low of $6.80 was recorded on 04/09/25. SMA at 50 days reached $17.30, while 200 days put it at $17.51.
Levels Of Support And Resistance For TVTX Stock
The 24-hour chart illustrates a support level at 14.81, which if violated will result in even more drops to 14.31. On the upside, there is a resistance level at 15.59. A further resistance level may holdings at 15.87. The Relative Strength Index (RSI) on the 14-day chart is 40.05, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.60, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 75.45%. Stochastics %K at 12.04% indicates the stock is a buying.
